A period from the initial authorisation of a medicine during which the marketing authorisation holder benefits from the exclusive rights to the…
Exclusion of a medicine from a medicine list (e.g. positive list), often resulting in exclusion from reimbursement.
In German: Delisting /…
One variant of a patient co-payment for a medicine, other health product or health service included in public funding (reimbursement). An initial…
A unit of measurement to specify the assumed average maintenance dose per day for a medicines used for its main indication in the adult. A DDD will…
A pricing and reimbursement model which decouples the price (and thus profitability) of a medicine from its sales volume (e.g., applied for…
A delivery chain is the system of organisations, people, technology, activities, information and resources involved in moving a product or service…
Cross-country approach of setting the price of medicine in accordance with the ability-to-pay, and/or the economic situation of the involved…
Payments for goods and services which are not covered by a third party payer (including self-medication).
Last update: 15 June 2023
Source: PPRI
A price reduction granted to specified purchasers under specific conditions prior to purchase.
Last update: 15 June 2023
Source: OECD, adapted by…
Eligibility for reimbursement is linked to the underlying disease which shall be treated.Last update: 21 June 2024Source: PPRI
Disinvestment relates to the process of withdrawing health resources, either partially or completely, from existing healthcare practices (including…
To supply a clinically appropriate medicine to a patient or care giver, usually against a written prescription, for self-administration or…